Comprehensive insight into endothelial progenitor cell-derived extracellular vesicles as a promising candidate for disease treatment

Stem Cell Res Ther. 2022 Jun 7;13(1):238. doi: 10.1186/s13287-022-02921-0.

Abstract

Endothelial progenitor cells (EPCs), which are a type of stem cell, have been found to have strong angiogenic and tissue repair capabilities. Extracellular vesicles (EVs) contain many effective components, such as cellular proteins, microRNAs, messenger RNAs, and long noncoding RNAs, and can be secreted by different cell types. The functions of EVs depend mainly on their parent cells. Many researchers have conducted functional studies of EPC-derived EVs (EPC-EVs) and showed that they exhibit therapeutic effects on many diseases, such as cardiovascular disease, acute kidney injury, acute lung injury, and sepsis. In this review article, we comprehensively summarized the biogenesis and functions of EPCs and EVs and the potent role of EPC-EVs in the treatment of various diseases. Furthermore, the current problems and future prospects have been discussed, and further studies are needed to compare the therapeutic effects of EVs derived from various stem cells, which will contribute to the accelerated translation of these applications in a clinical setting.

Keywords: Cell communication; Comprehensive review; Disease treatment; Endothelial progenitor cells; Extracellular vesicles.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Endothelial Progenitor Cells* / metabolism
  • Extracellular Vesicles* / metabolism
  • Humans
  • MicroRNAs* / metabolism
  • RNA, Long Noncoding* / metabolism
  • Sepsis* / metabolism

Substances

  • MicroRNAs
  • RNA, Long Noncoding